Status:
WITHDRAWN
Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time.
Lead Sponsor:
Rhode Island College
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Cessation
Weight Loss
Eligibility:
All Genders
18-64 years
Phase:
PHASE1
PHASE2
Brief Summary
The study has two phases. In Phase 1, the investigators will revise and pilot the distress tolerance (DT) protocol that was originally developed and piloted in a previous study (2P20 GM103430, Spas, P...
Detailed Description
In Phase 1, the investigators will revise the distress tolerance (DT) protocol the investigators developed in a previous study. Currently, the DT protocol is comprised of 6 two-hour weekly group sessi...
Eligibility Criteria
Inclusion
- between 18-64 years old
- have been a regular smoker for at least three years
- meet DSM-IV criteria for nicotine dependence
- smoke on average 10 cigarettes per day
- are overweight or obese (25\<BMI\<40)
- report motivation to quit smoking and lose weight
- speak English.
Exclusion
- engaged in a smoking cessation or weight loss intervention
- use medications known to affect smoking cessation or weight loss
- have a medical condition that is a contraindication for transdermal nicotine patch (TNP)
- regularly use other tobacco products
- endorse active suicidal or homicidal ideation
- self-report or meet diagnostic criteria for an alcohol or drug dependence
- self-report or meet diagnostic criteria for an eating or neurocognitive disorder
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04130698
Start Date
June 1 2019
End Date
July 31 2022
Last Update
October 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island College
Providence, Rhode Island, United States, 02908